Aggrecan and chondroitin-6-sulfate abnormalities in schizophrenia and bipolar disorder: A postmortem study on the amygdala

Translational Psychiatry

Volumn 5, Issue 1, 2015, Pages

  Pantazopoulos, H ^a,b   Markota, M ^a,b   Jaquet, F ^a   Ghosh, D ^a   Wallin, A ^a   Santos, A ^a   Caterson, B ^c   Berretta, S ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; CHONDROITIN 6 SULFATE; LECTIN; ACAN PROTEIN, HUMAN; CHONDROITIN SULFATE;

AMYGDALOID NUCLEUS; ARTICLE; AUTOPSY; BIPOLAR DISORDER; BRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; ENTORHINAL CORTEX; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MENTAL DISEASE; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; SCHIZOPHRENIA; ADULT; AGED; CASE CONTROL STUDY; FEMALE; GLIA; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AGGRECANS; AMYGDALA; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CHONDROITIN SULFATES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEUROGLIA; SCHIZOPHRENIA;

EID: 84927927110     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.128     Document Type: Article

References (106)

1. Pantazopoulos H, Boyer-Boiteau A, Holbrook EH, Jang W, Hahn CG, Arnold SE et al. Proteoglycan abnormalities in olfactory epithelium tissue from subjects diagnosed with schizophrenia. Schizophr Res 2013; 150: 366-372
2. Berretta S. Extracellular matrix abnormalities in schizophrenia. Neuropharmacology 2012; 62: 1584-1597
3. Pantazopoulos H, Woo T-UW, Lim MP, Lange N, Berretta S. Extracellular matrixglial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia. Arch Gen Psychiatry 2010; 67: 155-166
4. Mauney SA, Athanas KM, Pantazopoulos H, Shaskan N, Passeri E, Berretta S et al. Developmental pattern of perineuronal nets in the human prefrontal cortex and their deficit in schizophrenia. Biol Psychiatry 2013; 74: 427-435
5. Buxbaum JD, Georgieva L, Young JJ, Plescia C, Kajiwara Y, Jiang Y et al. Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene. Mol Psychiatry 2008; 13: 162-172
6. Muhleisen TW, Mattheisen M, Strohmaier J, Degenhardt F, Priebe L, Schultz CC et al. Association between schizophrenia and common variation in neurocan (NCAN), a genetic risk factor for bipolar disorder. Schizophr Res 2012; 138: 69-73
7. So HC, Fong PY, Chen RY, Hui TC, Ng MY, Cherny SS et al. Identification of neuroglycan C and interacting partners as potential susceptibility genes for schizophrenia in a Southern Chinese population. Am J Med Genet B Neuropsychiatr Genet 2010; 153B: 103-113
8. Cabungcal JH, Steullet P, Morishita H, Kraftsik R, Cuenod M, Hensch TK et al. Perineuronal nets protect fast-spiking interneurons against oxidative stress. Proc Natl Acad Sci USA 2013; 110: 9130-9135
9. Shah A, Lodge DJ. A loss of hippocampal perineuronal nets produces deficits in dopamine system function: relevance to the positive symptoms of schizophrenia. Transl Psychiatry 2013; 3: e215
10. Uhlhaas PJ, Singer W. Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 2010; 11: 100-113
11. Spencer KM. Visual gamma oscillations in schizophrenia: implications for understanding neural circuitry abnormalities. Clin EEG Neurosci 2008; 39: 65-68
12. Lewis DA, Hashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 2005; 6: 312-324
13. Woo TU, Miller JL, Lewis DA. Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. Am J Psychiatry 1997; 154: 1013-1015
14. Beneyto M, Kristiansen LV, Oni-Orisan A, McCullumsmith RE, Meador-Woodruff JH. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology 2007; 32: 1888-1902
15. Coyle JT. The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry 1996; 3: 241-253
16. Harrison PJ, Lyon L, Sartorius LJ, Burnet PW, Lane TA. The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia. J Psychopharmacol 2008; 22: 308-322
17. Javitt DC. Glutamatergic theories of schizophrenia. Isr J Psychiatry Relat Sci 2010; 47: 4-16
18. Akbarian S, Kim JJ, Potkin SG, Hetrick WP, Bunney WE Jr, Jones EG. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry 1996; 53: 425-436
19. Arnold SE. Neurodevelopmental abnormalities in schizophrenia: insights from neuropathology. Dev Psychopathol 1999; 11: 439-456
20. Yang Y, Fung SJ, Rothwell A, Tianmei S, Weickert CS. Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia. Biol Psychiatry 2011; 69: 63-70
21. Bernstein HG, Steiner J, Bogerts B. Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy. Expert Rev Neurother 2009; 9: 1059-1071
22. Halassa MM, Fellin T, Haydon PG. The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol Med 2007; 13: 54-63
23. Frischknecht R, Gundelfinger ED. The brain's extracellular matrix and its role in synaptic plasticity. Adv Exp Med Biol 2012; 970: 153-171
24. Dityatev A, Seidenbecher CI, Schachner M. Compartmentalization from the outside: The extracellular matrix and functional microdomains in the brain. Trends Neurosci 2010; 33: 503-512
25. Maeda N, Fukazawa N, Ishii M. Chondroitin sulfate proteoglycans in neural development and plasticity. Front Biosci 2010; 15: 626-644
26. Wang D, Fawcett J. The perineuronal net and the control of CNS plasticity. Cell Tissue Res 2012; 349: 147-160
27. Bandtlow CE, Zimmermann DR. Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol Rev 2000; 80: 1267-1290
28. Curran T, D'Arcangelo G. Role of reelin in the control of brain development. Brain Res Brain Res Rev 1998; 26: 285-294
29. Zimmermann DR, Dours-Zimmermann MT. Extracellular matrix of the central nervous system: from neglect to challenge. Histochem Cell Biol 2008; 130: 635-653
30. Dityatev A, Schachner M. The extracellular matrix and synapses. Cell Tissue Res 2006; 326: 647-654
31. Dityatev A, Schachner M, Sonderegger P. The dual role of the extracellular matrix in synaptic plasticity and homeostasis. Nat Rev Neurosci 2010; 11: 735-746
32. McRae PA, Rocco MM, Kelly G, Brumberg JC, Matthews RT. Sensory deprivation alters aggrecan and perineuronal net expression in the mouse barrel cortex. J Neurosci 2007; 27: 5405-5413
33. Gati G, Morawski M, Lendvai D, Matthews RT, Jager C, Zachar G et al. Chondroitin sulphate proteoglycan-based perineuronal net establishment is largely activityindependent in chick visual system. J Chem Neuroanat 2010; 40: 243-247
34. Ye Q, Miao QL. Experience-dependent development of perineuronal nets and chondroitin sulfate proteoglycan receptors in mouse visual cortex. Matrix Biol 2013; 32: 352-363
35. Faissner A, Pyka M, Geissler M, Sobik T, Frischknecht R, Gundelfinger ED et al. Contributions of astrocytes to synapse formation and maturation-potential functions of the perisynaptic extracellular matrix. Brain Res Rev 2010; 63: 26-38
36. Klausmeyer A, Conrad R, Faissner A, Wiese S. Influence of glial-derived matrix molecules, especially chondroitin sulfates, on neurite growth and survival of cultured mouse embryonic motoneurons. J Neurosci Res 2011; 89: 127-141
37. Wiese S, Karus M, Faissner A. Astrocytes as a source for extracellular matrix molecules and cytokines. Front Pharmacol 2012; 3: 120
38. Beurdeley M, Spatazza J, Lee HH, Sugiyama S, Bernard C, Di Nardo AA et al. Otx2 binding to perineuronal nets persistently regulates plasticity in the mature visual cortex. J Neurosci 2012; 32: 9429-9437
39. Bruckner G, Kacza J, Grosche J. Perineuronal nets characterized by vital labelling, confocal and electron microscopy in organotypic slice cultures of rat parietal cortex and hippocampus. J Mol Histol 2004; 35: 115-122
40. Celio MR. Perineuronal nets of extracellular matrix around parvalbumincontaining neurons of the hippocampus. Hippocampus 1993; 3 (Spec No): 55-60
41. Pantazopoulos H, Lange N, Hassinger L, Berretta S. Subpopulations of neurons expressing parvalbumin in the human amygdala. J Comp Neurol 2006; 496: 706-722
42. Maeda N. Structural variation of chondroitin sulfate and its roles in the central nervous system. Cent Nerv Syst Agents Med Chem 2010; 10: 22-31
43. Miyata S, Komatsu Y, Yoshimura Y, Taya C, Kitagawa H. Persistent cortical plasticity by upregulation of chondroitin 6-sulfation. Nat Neurosci 2012; 15: 414-422, S1-2
44. Caterson B, Griffin J, Mahmoodian F, Sorrell JM. Monoclonal antibodies against chondroitin sulphate isomers: their use as probes for investigating proteoglycan metabolism. Biochem Soc Trans 1990; 18: 820-823
45. Giamanco KA, Morawski M, Matthews RT. Perineuronal net formation and structure in aggrecan knockout mice. Neuroscience 2010; 170: 1314-1327
46. Giamanco KA, Matthews RT. Deconstructing the perineuronal net: cellular contributions and molecular composition of the neuronal extracellular matrix. Neuroscience 2012; 218: 367-384
47. Guimaraes A, Zaremba S, Hockfield S. Molecular and morphological changes in the cat lateral geniculate nucleus and visual cortex induced by visual deprivation are revealed by monoclonal antibodies Cat-304 and Cat-301. J Neurosci 1990; 10: 3014-3024
48. Kalb RG, Hockfield S. Molecular evidence for early activity-dependent development of hamster motor neurons. J Neurosci 1988; 8: 2350-2360
49. Gu WL, Fu SL, Wang YX, Li Y, Lu HZ, Xu XM et al. Chondroitin sulfate proteoglycans regulate the growth, differentiation and migration of multipotent neural precursor cells through the integrin signaling pathway. BMC Neurosci 2009; 10: 128
50. Caterson B. Fell-Muir Lecture: chondroitin sulphate glycosaminoglycans: fun for some and confusion for others. Int J Exp Pathol 2012; 93: 1-10
51. Sorrell JM, Mahmoodian F, Caterson B. Immunochemical and biochemical comparisons between embryonic chick bone marrow and epiphyseal cartilage chondroitin/dermatan sulphate proteoglycans. J Cell Sci 1988; 91: 81-90
52. Deepa SS, Yamada S, Fukui S, Sugahara K. Structural determination of novel sulfated octasaccharides isolated from chondroitin sulfate of shark cartilage and their application for characterizing monoclonal antibody epitopes. Glycobiology 2007; 17: 631-645
53. Ito Y, Hikino M, Yajima Y, Mikami T, Sirko S, von Holst A et al. Structural characterization of the epitopes of the monoclonal antibodies 473HD, CS-56, and MO-225 specific for chondroitin sulfate D-type using the oligosaccharide library. Glycobiology 2005; 15: 593-603
54. Coggeshall RE, Lekan HA. Methods for determining number of cells and synapses: A case for more uniform standard of review. J Comp Neurol 1996; 364: 6-15
55. Gundersen HJ, Jensen EB, Kieu K, Nielsen J. The efficiency of systematic sampling in stereology-reconsidered. J Microsc 1999; 193: 199-211
56. Matthews RT, Kelly GM, Zerillo CA, Gray G, Tiemeyer M, Hockfield S. Aggrecan glycoforms contribute to the molecular heterogeneity of perineuronal nets. J Neurosci 2002; 22: 7536-7547
57. Yin ZQ, Crewther SG, Wang C, Crewther DP. Pre-and post-critical period induced reduction of Cat-301 immunoreactivity in the lateral geniculate nucleus and visual cortex of cats Y-blocked as adults or made strabismic as kittens. Mol Vis 2006; 12: 858-866
58. Kurokawa T, Tsuda M, Sugino Y. Purification and characterization of a lectin from Wistaria floribunda seeds. J Biol Chem 1976; 251: 5686-5693
59. Dityatev A, Bruckner G, Dityateva G, Grosche J, Kleene R, Schachner M. Activitydependent formation and functions of chondroitin sulfate-rich extracellular matrix of perineuronal nets. Dev Neurobiol 2007; 67: 570-588
60. Galtrey CM, Fawcett JW. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res Rev 2007; 54: 1-18
61. Hartig W, Brauer K, Bigl V, Bruckner G. Chondroitin sulfate proteoglycanimmunoreactivity of lectin-labeled perineuronal nets around parvalbumincontaining neurons. Brain Res 1994; 635: 307-311
62. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408
63. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C (T) method. Nat Protoc 2008; 3: 1101-1108
64. Sims KS, Williams RS. The human amygdaloid complex: A cytologic and histochemical atlas using Nissl, myelin, acetylcholinesterase and nicotinamide adenine dinucleotide phosphate diaphorase staining. Neuroscience 1990; 36: 449-472
65. Amaral DG Price JL Pitkanen A Carmichael ST. Anatomical organization of the primate amygdaloid complex. In: Aggleton, JP (ed). The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction. Wiley-Liss: New York, NY, USA, 1992
66. Sorvari H, Soininen H, Paljarvi L, Karkola K, Pitkanen A. Distribution of parvalbumin-immunoreactive cells and fibers in the human amygdaloid complex. J Comp Neurol 1995; 360: 185-212
67. Pantazopoulos H, Murray EA, Berretta S. Total number, distribution, and phenotype of cells expressing chondroitin sulfate proteoglycans in the normal human amygdala. Brain Res 2008; 1207: 84-95
68. Berretta S, Pantazopoulos H, Lange N. Neuron numbers and volume of the amygdala in subjects diagnosed with bipolar disorder or schizophrenia. Biol Psychiatry 2007; 62: 884-893
69. Baldessarini RJ Tarazi FI. Pharmacotherapy of psychosis and mania. In: Brunton, LL, Lazo, JS, Parker, KL (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics, 11th edn. McGraw-Hill Press: New York, NY, USA, 1995. 461-500
70. Hayashi N, Tatsumi K, Okuda H, Yoshikawa M, Ishizaka S, Miyata S et al. DACS, novel matrix structure composed of chondroitin sulfate proteoglycan in the brain. Biochem Biophys Res Commun 2007; 364: 410-415
71. Yick LW, So KF, Cheung PT, Wu WT. Lithium chloride reinforces the regenerationpromoting effect of chondroitinase ABC on rubrospinal neurons after spinal cord injury. J Neurotrauma 2004; 21: 932-943
72. Frederick JP, Tafari AT, Wu SM, Megosh LC, Chiou ST, Irving RP et al. A role for a lithium-inhibited Golgi nucleotidase in skeletal development and sulfation. Proc Natl Acad Sci USA 2008; 105: 11605-11612
73. Ojima H, Kuroda M, Ohyama J, Kishi K. Two classes of cortical neurones labelled with Vicia villosa lectin in the guinea-pig. Neuroreport 1995; 6: 617-620
74. Celio MR, Blumcke I. Perineuronal nets-a specialized form of extracellular matrix in the adult nervous system. Brain Res Brain Res Rev 1994; 19: 128-145
75. Fryer HJ, Kelly GM, Molinaro L, Hockfield S. The high molecular weight Cat-301 chondroitin sulfate proteoglycan from brain is related to the large aggregating proteoglycan from cartilage, aggrecan. J Biol Chem 1992; 267: 9874-9883
76. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000; 28: 53-67
77. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 2004; 9: 684-697, 43
78. Dityatev A, Brückner G, Dityateva G, Grosche J, Kleene R, Schachner M. Activitydependent formation and functions of chondroitin sulfate-rich extracellular matrix of perineuronal nets. Dev Neurobiol 2007; 67: 570-588
79. Carulli D, Rhodes KE, Fawcett JW. Upregulation of aggrecan, link protein 1, and hyaluronan synthases during formation of perineuronal nets in the rat cerebellum. J Comp Neurol 2007; 501: 83-94
80. Kwok JC, Carulli D, Fawcett JW. In vitro modeling of perineuronal nets: hyaluronan synthase and link protein are necessary for their formation and integrity. J Neurochem 2010; 114: 1447-1459
81. Consortium TSPG-WASG. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011; 43: 969-976
82. Gogolla N, Caroni P, Luthi A, Herry C. Perineuronal nets protect fear memories from erasure. Science 2009; 325: 1258-1261
83. Pizzorusso T, Medini P, Berardi N, Chierzi S, Fawcett JW, Maffei L. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 2002; 298: 1248-1251
84. Matsumoto-Miyai K, Sokolowska E, Zurlinden A, Gee CE, Luscher D, Hettwer S et al. Coincident pre-and postsynaptic activation induces dendritic filopodia via neurotrypsin-dependent agrin cleavage. Cell 2009; 136: 1161-1171
85. Dall'Oglio A, Xavier LL, Hilbig A, Ferme D, Moreira JE, Achaval M et al. Cellular components of the human medial amygdaloid nucleus. J Comp Neurol 2013; 521: 589-611
86. Dityatev A, Rusakov DA. Molecular signals of plasticity at the tetrapartite synapse. Curr Opin Neurobiol 2011; 21: 353-359
87. Frischknecht R, Heine M, Perrais D, Seidenbecher CI, Choquet D, Gundelfinger ED. Brain extracellular matrix affects AMPA receptor lateral mobility and shortterm synaptic plasticity. Nat Neurosci 2009; 12: 897-904
88. Gundelfinger ED, Frischknecht R, Choquet D, Heine M. Converting juvenile into adult plasticity: A role for the brain's extracellular matrix. Eur J Neurosci 2010; 31: 2156-2165
89. Vigetti D, Andrini O, Clerici M, Negrini D, Passi A, Moriondo A. Chondroitin sulfates act as extracellular gating modifiers on voltage-dependent ion channels. Cell Physiol Biochem 2008; 22: 137-146
90. Kochlamazashvili G, Henneberger C, Bukalo O, Dvoretskova E, Senkov O, Lievens PM et al. The extracellular matrix molecule hyaluronic acid regulates hippocampal synaptic plasticity by modulating postsynaptic L-type Ca(2+) channels. Neuron 2010; 67: 116-128
91. Bukalo O, Schachner M, Dityatev A. Modification of extracellular matrix by enzymatic removal of chondroitin sulfate and by lack of tenascin-R differentially affects several forms of synaptic plasticity in the hippocampus. Neuroscience 2001; 104: 359-369
92. Zhou XH, Brakebusch C, Matthies H, Oohashi T, Hirsch E, Moser M et al. Neurocan is dispensable for brain development. Mol Cell Biol. 2001; 21: 5970-5978
93. Brakebusch C, Seidenbecher CI, Asztely F, Rauch U, Matthies H, Meyer H et al. Brevican-deficient mice display impaired hippocampal CA1 long-term potentiation but show no obvious deficits in learning and memory. Mol Cell Biol 2002; 22: 7417-7427
94. Holt DJ, Coombs G, Zeidan MA, Goff DC, Milad MR. Failure of neural responses to safety cues in schizophrenia. Arch Gen Psychiatry 2012; 69: 893-903
95. Shin JW, Geerling JC, Loewy AD. Inputs to the ventrolateral bed nucleus of the stria terminalis. J Comp Neurol 2008; 511: 628-657
96. Walker DL, Davis M. Role of the extended amygdala in short-duration versus sustained fear: A tribute to Dr. Lennart Heimer. Brain Struct Funct 2008; 213: 29-42
97. Maren S, Phan KL, Liberzon I. The contextual brain: implications for fear conditioning, extinction and psychopathology. Nat Rev Neurosci 2013; 14: 417-428
98. Li Z, Richter-Levin G. Priming stimulation of basal but not lateral amygdala affects long-term potentiation in the rat dentate gyrus in vivo. Neuroscience 2013; 246: 13-21
99. Siddiqui S, Horvat-Brocker A, Faissner A. The glia-derived extracellular matrix glycoprotein tenascin-C promotes embryonic and postnatal retina axon outgrowth via the alternatively spliced fibronectin type III domain TNfnD. Neuron Glia Biol 2008; 4: 271-283
100. Horii-Hayashi N, Tatsumi K, Matsusue Y, Okuda H, Okuda A, Hayashi M et al. Chondroitin sulfate demarcates astrocytic territories in the mammalian cerebral cortex. Neurosci Lett 2010; 483: 67-72
101. Okuda H, Tatsumi K, Morita S, Shibukawa Y, Korekane H, Horii-Hayashi N et al. Chondroitin sulfate proteoglycan tenascin-R regulates glutamate uptake by adult brain astrocytes. J Biol Chem 2014; 289: 2620-2631
102. Bridges R, Lutgen V, Lobner D, Baker DA. Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling. Pharmacol Rev 2012; 64: 780-802
103. Shan D, Yates S, Roberts RC, McCullumsmith RE. Update on the neurobiology of schizophrenia: A role for extracellular microdomains. Minerva psichiatr 2012; 53: 233-249
104. Ye ZC, Sontheimer H. Modulation of glial glutamate transport through cell interactions with the extracellular matrix. Int J Dev Neurosci 2002; 20: 209-217
105. Goudriaan A, de Leeuw C, Ripke S, Hultman CM, Sklar P, Sullivan PF et al. Specific glial functions contribute to schizophrenia susceptibility. Schizophr Bull 2013; 40: 925-935
106. Meador-Woodruff JH, Healy DJ. Glutamate receptor expression in schizophrenic brain. Brain Res Brain Res Rev 2000; 31: 288-294.